カテゴリー： Market Monitor Global, 世界, 医療/バイオ

骨吸収阻害剤の世界市場見通し2023年-2029年

◆英語タイトル：Bone Resorption Inhibitors Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5140）

◆商品コード：MMG23JU5140
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：114
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Bone Resorption Inhibitors Market 調査レポートは次の情報を含め、グローバルにおけるの骨吸収阻害剤市場規模と予測を収録しています。・世界の骨吸収阻害剤市場：売上、2018年-2023年、2024年-2029年
・世界の骨吸収阻害剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の骨吸収阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口式」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

骨吸収阻害剤のグローバル主要企業は、Novartis、 Pfizer、 Amgen、 Apotex、 Athenex Pharmaceuticl Divison、 BPI Labs、 Cipla USA、 Merck、 Mylan Institutional、 Sagent Pharmaceuticals、 Accord Healthcare、 Fresenius Kabi、 Dr. Reddy's Laboratories、 Viatris、 Hikma Pharmaceuticals、 Aurobindo Pharma、 Akorn、 Teva Pharmaceuticals、 Sun Pharma、 Sun Pharmaceutical Industriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、骨吸収阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の骨吸収阻害剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の骨吸収阻害剤市場：タイプ別市場シェア、2022年
・経口式、非経口式

世界の骨吸収阻害剤市場：用途別、2018年-2023年、2024年-2029年
世界の骨吸収阻害剤市場：用途別市場シェア、2022年
・骨巨細胞腫、高カルシウム血症、骨粗鬆症、その他

世界の骨吸収阻害剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の骨吸収阻害剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における骨吸収阻害剤のグローバル売上、2018年-2023年
・主要企業における骨吸収阻害剤のグローバル売上シェア、2022年
・主要企業における骨吸収阻害剤のグローバル販売量、2018年-2023年
・主要企業における骨吸収阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Pfizer、 Amgen、 Apotex、 Athenex Pharmaceuticl Divison、 BPI Labs、 Cipla USA、 Merck、 Mylan Institutional、 Sagent Pharmaceuticals、 Accord Healthcare、 Fresenius Kabi、 Dr. Reddy's Laboratories、 Viatris、 Hikma Pharmaceuticals、 Aurobindo Pharma、 Akorn、 Teva Pharmaceuticals、 Sun Pharma、 Sun Pharmaceutical Industries

*************************************************************

・調査・分析レポートの概要
骨吸収阻害剤市場の定義
市場セグメント
世界の骨吸収阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の骨吸収阻害剤市場規模
世界の骨吸収阻害剤市場規模：2022年 VS 2029年
世界の骨吸収阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの骨吸収阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の骨吸収阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口式、非経口式
骨吸収阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：骨巨細胞腫、高カルシウム血症、骨粗鬆症、その他
骨吸収阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別骨吸収阻害剤市場規模 2022年と2029年
地域別骨吸収阻害剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Pfizer、 Amgen、 Apotex、 Athenex Pharmaceuticl Divison、 BPI Labs、 Cipla USA、 Merck、 Mylan Institutional、 Sagent Pharmaceuticals、 Accord Healthcare、 Fresenius Kabi、 Dr. Reddy's Laboratories、 Viatris、 Hikma Pharmaceuticals、 Aurobindo Pharma、 Akorn、 Teva Pharmaceuticals、 Sun Pharma、 Sun Pharmaceutical Industries
...

This report aims to provide a comprehensive presentation of the global market for Bone Resorption Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Resorption Inhibitors. This report contains market size and forecasts of Bone Resorption Inhibitors in global, including the following market information:
Global Bone Resorption Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Bone Resorption Inhibitors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bone Resorption Inhibitors include Novartis, Pfizer, Amgen, Apotex, Athenex Pharmaceuticl Divison, BPI Labs, Cipla USA, Merck and Mylan Institutional, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bone Resorption Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bone Resorption Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Bone Resorption Inhibitors Market Segment Percentages, by Type, 2022 (%)
Oral
Parenteral
Global Bone Resorption Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Bone Resorption Inhibitors Market Segment Percentages, by Application, 2022 (%)
Giant Cell Tumor of Bone
Hypercalcemia
Osteoporosis
Others
Global Bone Resorption Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Bone Resorption Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bone Resorption Inhibitors revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Bone Resorption Inhibitors revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Amgen
Apotex
Athenex Pharmaceuticl Divison
BPI Labs
Cipla USA
Merck
Mylan Institutional
Sagent Pharmaceuticals
Accord Healthcare
Fresenius Kabi
Dr. Reddy’s Laboratories
Viatris
Hikma Pharmaceuticals
Aurobindo Pharma
Akorn
Teva Pharmaceuticals
Sun Pharma
Sun Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bone Resorption Inhibitors, market overview.
Chapter 2: Global Bone Resorption Inhibitors market size in revenue.
Chapter 3: Detailed analysis of Bone Resorption Inhibitors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bone Resorption Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Bone Resorption Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bone Resorption Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bone Resorption Inhibitors Overall Market Size
2.1 Global Bone Resorption Inhibitors Market Size: 2022 VS 2029
2.2 Global Bone Resorption Inhibitors Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bone Resorption Inhibitors Players in Global Market
3.2 Top Global Bone Resorption Inhibitors Companies Ranked by Revenue
3.3 Global Bone Resorption Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Bone Resorption Inhibitors Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bone Resorption Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bone Resorption Inhibitors Players in Global Market
3.6.1 List of Global Tier 1 Bone Resorption Inhibitors Companies
3.6.2 List of Global Tier 2 and Tier 3 Bone Resorption Inhibitors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Bone Resorption Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type – Global Bone Resorption Inhibitors Revenue & Forecasts
4.2.1 By Type – Global Bone Resorption Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global Bone Resorption Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bone Resorption Inhibitors Market Size, 2022 & 2029
5.1.2 Giant Cell Tumor of Bone
5.1.3 Hypercalcemia
5.1.4 Osteoporosis
5.1.5 Others
5.2 By Application – Global Bone Resorption Inhibitors Revenue & Forecasts
5.2.1 By Application – Global Bone Resorption Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global Bone Resorption Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Bone Resorption Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global Bone Resorption Inhibitors Revenue & Forecasts
6.2.1 By Region – Global Bone Resorption Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global Bone Resorption Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Bone Resorption Inhibitors Revenue, 2018-2029
6.3.2 US Bone Resorption Inhibitors Market Size, 2018-2029
6.3.3 Canada Bone Resorption Inhibitors Market Size, 2018-2029
6.3.4 Mexico Bone Resorption Inhibitors Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Bone Resorption Inhibitors Revenue, 2018-2029
6.4.2 Germany Bone Resorption Inhibitors Market Size, 2018-2029
6.4.3 France Bone Resorption Inhibitors Market Size, 2018-2029
6.4.4 U.K. Bone Resorption Inhibitors Market Size, 2018-2029
6.4.5 Italy Bone Resorption Inhibitors Market Size, 2018-2029
6.4.6 Russia Bone Resorption Inhibitors Market Size, 2018-2029
6.4.7 Nordic Countries Bone Resorption Inhibitors Market Size, 2018-2029
6.4.8 Benelux Bone Resorption Inhibitors Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Bone Resorption Inhibitors Revenue, 2018-2029
6.5.2 China Bone Resorption Inhibitors Market Size, 2018-2029
6.5.3 Japan Bone Resorption Inhibitors Market Size, 2018-2029
6.5.4 South Korea Bone Resorption Inhibitors Market Size, 2018-2029
6.5.5 Southeast Asia Bone Resorption Inhibitors Market Size, 2018-2029
6.5.6 India Bone Resorption Inhibitors Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Bone Resorption Inhibitors Revenue, 2018-2029
6.6.2 Brazil Bone Resorption Inhibitors Market Size, 2018-2029
6.6.3 Argentina Bone Resorption Inhibitors Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Bone Resorption Inhibitors Revenue, 2018-2029
6.7.2 Turkey Bone Resorption Inhibitors Market Size, 2018-2029
6.7.3 Israel Bone Resorption Inhibitors Market Size, 2018-2029
6.7.4 Saudi Arabia Bone Resorption Inhibitors Market Size, 2018-2029
6.7.5 UAE Bone Resorption Inhibitors Market Size, 2018-2029
7 Bone Resorption Inhibitors Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Bone Resorption Inhibitors Major Product Offerings
7.1.4 Novartis Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Bone Resorption Inhibitors Major Product Offerings
7.2.4 Pfizer Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Bone Resorption Inhibitors Major Product Offerings
7.3.4 Amgen Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Apotex
7.4.1 Apotex Company Summary
7.4.2 Apotex Business Overview
7.4.3 Apotex Bone Resorption Inhibitors Major Product Offerings
7.4.4 Apotex Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.4.5 Apotex Key News & Latest Developments
7.5 Athenex Pharmaceuticl Divison
7.5.1 Athenex Pharmaceuticl Divison Company Summary
7.5.2 Athenex Pharmaceuticl Divison Business Overview
7.5.3 Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Major Product Offerings
7.5.4 Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.5.5 Athenex Pharmaceuticl Divison Key News & Latest Developments
7.6 BPI Labs
7.6.1 BPI Labs Company Summary
7.6.2 BPI Labs Business Overview
7.6.3 BPI Labs Bone Resorption Inhibitors Major Product Offerings
7.6.4 BPI Labs Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.6.5 BPI Labs Key News & Latest Developments
7.7 Cipla USA
7.7.1 Cipla USA Company Summary
7.7.2 Cipla USA Business Overview
7.7.3 Cipla USA Bone Resorption Inhibitors Major Product Offerings
7.7.4 Cipla USA Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.7.5 Cipla USA Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Bone Resorption Inhibitors Major Product Offerings
7.8.4 Merck Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Mylan Institutional
7.9.1 Mylan Institutional Company Summary
7.9.2 Mylan Institutional Business Overview
7.9.3 Mylan Institutional Bone Resorption Inhibitors Major Product Offerings
7.9.4 Mylan Institutional Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.9.5 Mylan Institutional Key News & Latest Developments
7.10 Sagent Pharmaceuticals
7.10.1 Sagent Pharmaceuticals Company Summary
7.10.2 Sagent Pharmaceuticals Business Overview
7.10.3 Sagent Pharmaceuticals Bone Resorption Inhibitors Major Product Offerings
7.10.4 Sagent Pharmaceuticals Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.10.5 Sagent Pharmaceuticals Key News & Latest Developments
7.11 Accord Healthcare
7.11.1 Accord Healthcare Company Summary
7.11.2 Accord Healthcare Business Overview
7.11.3 Accord Healthcare Bone Resorption Inhibitors Major Product Offerings
7.11.4 Accord Healthcare Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.11.5 Accord Healthcare Key News & Latest Developments
7.12 Fresenius Kabi
7.12.1 Fresenius Kabi Company Summary
7.12.2 Fresenius Kabi Business Overview
7.12.3 Fresenius Kabi Bone Resorption Inhibitors Major Product Offerings
7.12.4 Fresenius Kabi Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.12.5 Fresenius Kabi Key News & Latest Developments
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Company Summary
7.13.2 Dr. Reddy’s Laboratories Business Overview
7.13.3 Dr. Reddy’s Laboratories Bone Resorption Inhibitors Major Product Offerings
7.13.4 Dr. Reddy’s Laboratories Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.13.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.14 Viatris
7.14.1 Viatris Company Summary
7.14.2 Viatris Business Overview
7.14.3 Viatris Bone Resorption Inhibitors Major Product Offerings
7.14.4 Viatris Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.14.5 Viatris Key News & Latest Developments
7.15 Hikma Pharmaceuticals
7.15.1 Hikma Pharmaceuticals Company Summary
7.15.2 Hikma Pharmaceuticals Business Overview
7.15.3 Hikma Pharmaceuticals Bone Resorption Inhibitors Major Product Offerings
7.15.4 Hikma Pharmaceuticals Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.15.5 Hikma Pharmaceuticals Key News & Latest Developments
7.16 Aurobindo Pharma
7.16.1 Aurobindo Pharma Company Summary
7.16.2 Aurobindo Pharma Business Overview
7.16.3 Aurobindo Pharma Bone Resorption Inhibitors Major Product Offerings
7.16.4 Aurobindo Pharma Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.16.5 Aurobindo Pharma Key News & Latest Developments
7.17 Akorn
7.17.1 Akorn Company Summary
7.17.2 Akorn Business Overview
7.17.3 Akorn Bone Resorption Inhibitors Major Product Offerings
7.17.4 Akorn Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.17.5 Akorn Key News & Latest Developments
7.18 Teva Pharmaceuticals
7.18.1 Teva Pharmaceuticals Company Summary
7.18.2 Teva Pharmaceuticals Business Overview
7.18.3 Teva Pharmaceuticals Bone Resorption Inhibitors Major Product Offerings
7.18.4 Teva Pharmaceuticals Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.18.5 Teva Pharmaceuticals Key News & Latest Developments
7.19 Sun Pharma
7.19.1 Sun Pharma Company Summary
7.19.2 Sun Pharma Business Overview
7.19.3 Sun Pharma Bone Resorption Inhibitors Major Product Offerings
7.19.4 Sun Pharma Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.19.5 Sun Pharma Key News & Latest Developments
7.20 Sun Pharmaceutical Industries
7.20.1 Sun Pharmaceutical Industries Company Summary
7.20.2 Sun Pharmaceutical Industries Business Overview
7.20.3 Sun Pharmaceutical Industries Bone Resorption Inhibitors Major Product Offerings
7.20.4 Sun Pharmaceutical Industries Bone Resorption Inhibitors Revenue in Global Market (2018-2023)
7.20.5 Sun Pharmaceutical Industries Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Bone Resorption Inhibitors Market Opportunities & Trends in Global Market
Table 2. Bone Resorption Inhibitors Market Drivers in Global Market
Table 3. Bone Resorption Inhibitors Market Restraints in Global Market
Table 4. Key Players of Bone Resorption Inhibitors in Global Market
Table 5. Top Bone Resorption Inhibitors Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bone Resorption Inhibitors Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bone Resorption Inhibitors Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bone Resorption Inhibitors Product Type
Table 9. List of Global Tier 1 Bone Resorption Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bone Resorption Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Bone Resorption Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Bone Resorption Inhibitors Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bone Resorption Inhibitors Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Bone Resorption Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Bone Resorption Inhibitors Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bone Resorption Inhibitors Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Bone Resorption Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Bone Resorption Inhibitors Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bone Resorption Inhibitors Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bone Resorption Inhibitors Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bone Resorption Inhibitors Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bone Resorption Inhibitors Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bone Resorption Inhibitors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bone Resorption Inhibitors Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Bone Resorption Inhibitors Product Offerings
Table 32. Novartis Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Bone Resorption Inhibitors Product Offerings
Table 36. Pfizer Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen Bone Resorption Inhibitors Product Offerings
Table 40. Amgen Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Apotex Company Summary
Table 43. Apotex Bone Resorption Inhibitors Product Offerings
Table 44. Apotex Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 45. Apotex Key News & Latest Developments
Table 46. Athenex Pharmaceuticl Divison Company Summary
Table 47. Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Product Offerings
Table 48. Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 49. Athenex Pharmaceuticl Divison Key News & Latest Developments
Table 50. BPI Labs Company Summary
Table 51. BPI Labs Bone Resorption Inhibitors Product Offerings
Table 52. BPI Labs Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 53. BPI Labs Key News & Latest Developments
Table 54. Cipla USA Company Summary
Table 55. Cipla USA Bone Resorption Inhibitors Product Offerings
Table 56. Cipla USA Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 57. Cipla USA Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Bone Resorption Inhibitors Product Offerings
Table 60. Merck Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Mylan Institutional Company Summary
Table 63. Mylan Institutional Bone Resorption Inhibitors Product Offerings
Table 64. Mylan Institutional Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 65. Mylan Institutional Key News & Latest Developments
Table 66. Sagent Pharmaceuticals Company Summary
Table 67. Sagent Pharmaceuticals Bone Resorption Inhibitors Product Offerings
Table 68. Sagent Pharmaceuticals Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 69. Sagent Pharmaceuticals Key News & Latest Developments
Table 70. Accord Healthcare Company Summary
Table 71. Accord Healthcare Bone Resorption Inhibitors Product Offerings
Table 72. Accord Healthcare Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 73. Accord Healthcare Key News & Latest Developments
Table 74. Fresenius Kabi Company Summary
Table 75. Fresenius Kabi Bone Resorption Inhibitors Product Offerings
Table 76. Fresenius Kabi Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 77. Fresenius Kabi Key News & Latest Developments
Table 78. Dr. Reddy's Laboratories Company Summary
Table 79. Dr. Reddy's Laboratories Bone Resorption Inhibitors Product Offerings
Table 80. Dr. Reddy's Laboratories Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 81. Dr. Reddy's Laboratories Key News & Latest Developments
Table 82. Viatris Company Summary
Table 83. Viatris Bone Resorption Inhibitors Product Offerings
Table 84. Viatris Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 85. Viatris Key News & Latest Developments
Table 86. Hikma Pharmaceuticals Company Summary
Table 87. Hikma Pharmaceuticals Bone Resorption Inhibitors Product Offerings
Table 88. Hikma Pharmaceuticals Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 89. Hikma Pharmaceuticals Key News & Latest Developments
Table 90. Aurobindo Pharma Company Summary
Table 91. Aurobindo Pharma Bone Resorption Inhibitors Product Offerings
Table 92. Aurobindo Pharma Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 93. Aurobindo Pharma Key News & Latest Developments
Table 94. Akorn Company Summary
Table 95. Akorn Bone Resorption Inhibitors Product Offerings
Table 96. Akorn Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 97. Akorn Key News & Latest Developments
Table 98. Teva Pharmaceuticals Company Summary
Table 99. Teva Pharmaceuticals Bone Resorption Inhibitors Product Offerings
Table 100. Teva Pharmaceuticals Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 101. Teva Pharmaceuticals Key News & Latest Developments
Table 102. Sun Pharma Company Summary
Table 103. Sun Pharma Bone Resorption Inhibitors Product Offerings
Table 104. Sun Pharma Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 105. Sun Pharma Key News & Latest Developments
Table 106. Sun Pharmaceutical Industries Company Summary
Table 107. Sun Pharmaceutical Industries Bone Resorption Inhibitors Product Offerings
Table 108. Sun Pharmaceutical Industries Bone Resorption Inhibitors Revenue (US$, Mn) & (2018-2023)
Table 109. Sun Pharmaceutical Industries Key News & Latest Developments
List of Figures
Figure 1. Bone Resorption Inhibitors Segment by Type in 2022
Figure 2. Bone Resorption Inhibitors Segment by Application in 2022
Figure 3. Global Bone Resorption Inhibitors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bone Resorption Inhibitors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bone Resorption Inhibitors Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bone Resorption Inhibitors Revenue in 2022
Figure 8. By Type - Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 9. By Application - Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 10. By Type - Global Bone Resorption Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 12. By Application - Global Bone Resorption Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 14. By Region - Global Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 15. By Country - North America Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 16. US Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 20. Germany Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 21. France Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 28. China Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 32. India Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 34. Brazil Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Bone Resorption Inhibitors Revenue Market Share, 2018-2029
Figure 37. Turkey Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Bone Resorption Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Apotex Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BPI Labs Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cipla USA Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Mylan Institutional Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sagent Pharmaceuticals Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Accord Healthcare Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Fresenius Kabi Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Dr. Reddy's Laboratories Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Viatris Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Hikma Pharmaceuticals Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Aurobindo Pharma Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Akorn Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Teva Pharmaceuticals Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Sun Pharma Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Sun Pharmaceutical Industries Bone Resorption Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 骨吸収阻害剤の世界市場見通し2023年-2029年(Bone Resorption Inhibitors Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

骨吸収阻害剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp